COMPASS-Hub research study is completed – September 2021

We teamed up with Kidney Care UK, Crohn’s & Colitis UK, Psoriasis Association, MS Society and to conduct a randomised controlled trial to evaluate the benefits of COMPASS for people with kidney disease, IBD, psoriasis and MS.

Eligible participants received either charity support or COMPASS for a period of 10 weeks and completed questionnaires and interviews with the research team to give feedback and allow the team to evaluate their progress.

Data analyses is underway and findings will be submitted for publication in peer-reviewed journals.

To find out how we are working with Kidney Care UK check out their web-page and blog post:

To see how we are working with Crohn’s & Colitis UK, click here:

To read the MS Society’s blog about the project, click here:


During a pandemic, how can we try and keep ourselves mentally and physically well? This is the question the Division of Psychology at the IoPPN answered in a series of talks at the virtual event ‘Maintaining health and well-being during the COVID-19 pandemic’ on 2nd April 2020.

Below, is a link with the video recordings of all of the talks.

For further information and advice about COVID-19 you can visit the NHS or websites: